Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (61-70 of 646) with videos related to

Pageof 65
Sort By:
European Journal of Internal Medicine|June 26, 2012
Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia?James D Chalmers, Julia Rutherford
Lancet (London, England)|January 30, 2010
Budesonide and risk of pneumoniaAran Singanayagam, James D Chalmers
American Journal of Respiratory and Critical Care Medicine|December 21, 2019
Happy Birthday, Bronchiectasis: 200 Years of Targeting MucusJames D Chalmers, Oriol Sibila
Seminars in Respiratory and Critical Care Medicine|December 14, 2016
Community-Acquired Pneumonia: A Global PerspectiveCharles Feldman, James D Chalmers
ERJ Open Research|September 3, 2025
Viruses in bronchiectasisClaire Baker, James D Chalmers
The European Respiratory Journal|June 3, 2020
Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortalityMike Lonergan, James D Chalmers
The European Respiratory Journal|September 10, 2020
A cuckoo COVID coincidence?James D Chalmers, Mike Lonergan
The European Respiratory Journal|January 6, 2018
Turning thirty: evolution but not revolution at the <i>ERJ</i>Martin Kolb, James D Chalmers
The European Respiratory Journal|January 6, 2018
Macrolides, mucoactive drugs and adherence for the management of bronchiectasisJames D Chalmers, Eva Polverino,
Chest|October 7, 2023
Inhaled Corticosteroids in COPD and Bronchiectasis: Use Biomarkers Rather Than Disease LabelsJames D Chalmers, Amelia Shoemark
Pageof 65

Showing results (61-70 of 646) with videos related to

Sort By:
Pageof 65
European Journal of Internal Medicine|June 26, 2012
Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia?James D Chalmers, Julia Rutherford
Lancet (London, England)|January 30, 2010
Budesonide and risk of pneumoniaAran Singanayagam, James D Chalmers
American Journal of Respiratory and Critical Care Medicine|December 21, 2019
Happy Birthday, Bronchiectasis: 200 Years of Targeting MucusJames D Chalmers, Oriol Sibila
Seminars in Respiratory and Critical Care Medicine|December 14, 2016
Community-Acquired Pneumonia: A Global PerspectiveCharles Feldman, James D Chalmers
ERJ Open Research|September 3, 2025
Viruses in bronchiectasisClaire Baker, James D Chalmers
The European Respiratory Journal|June 3, 2020
Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortalityMike Lonergan, James D Chalmers
The European Respiratory Journal|September 10, 2020
A cuckoo COVID coincidence?James D Chalmers, Mike Lonergan
The European Respiratory Journal|January 6, 2018
Turning thirty: evolution but not revolution at the <i>ERJ</i>Martin Kolb, James D Chalmers
The European Respiratory Journal|January 6, 2018
Macrolides, mucoactive drugs and adherence for the management of bronchiectasisJames D Chalmers, Eva Polverino,
Chest|October 7, 2023
Inhaled Corticosteroids in COPD and Bronchiectasis: Use Biomarkers Rather Than Disease LabelsJames D Chalmers, Amelia Shoemark
Pageof 65